Conference Coverage
Latest News
The earlier the better for colchicine post-MI: COLCOT
One substudy supported in-hospital initiation of colchicine and a second offered clues as to who may respond or experience tell-tale GI events.
Conference Coverage
Lessons for patients with MS and COVID-19
Patients with MS and COVID-19 avoided disease reactivation with combined PCR-serology testing and continued MS therapies with good results.
Conference Coverage
Experts advocate for the elimination of daylight savings time
The AASM recommends a permanent year-round standard time.
Conference Coverage
Final EVAPORATE results for Vascepa raise eyebrows
The 18-month data showed high-dose icosapent ethyl significantly cut plaque progression but did little to ease old concerns and raised only new...
Conference Coverage
Early evolocumab quickly lowers LDL cholesterol after primary PCI
Administration of evolocumab after PCI significantly improved LDL cholesterol levels within 4 weeks.
Conference Coverage
LoDoCo2: Added steam for colchicine as secondary prevention
The benefits emerged early and continued to accrue through the trial, with no suggestion of attenuation during up to 5 years of treatment.
Conference Coverage
REALITY trial supports restrictive transfusion in anemic MI
Restrictive transfusion proves more effective and less costly than liberal transfusion.
Conference Coverage
First randomized trial reassures on ACEIs, ARBs in COVID-19
The BRACE CORONA study found no difference in key outcomes between patients continuing versus stopping their medication.
Conference Coverage
Pandemic worsens disparities in GI and liver disease
Creative local solutions are needed to address screening and health care problems.
Conference Coverage
HOME-PE trial clarifies which pulmonary embolism patients to treat at home
“Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides
Conference Coverage
ESC’s revised NSTE-ACS guidelines embrace hsT, personalized anti-ischemia treatments